Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Effect of superdisintegrant type and concentration on dissolution behaviour of Ondansetron orodispersible tablets

Mohammed Sattar1,2 , Malathe Alshawi1, Neven Nsaif Jasim1

1Department of Pharmaceutics, College of Pharmacy, University of Basrah,; 2College of Pharmacy, Al-Farqadein University College, Basrah, Iraq.

For correspondence:-  Mohammed Sattar   Email: mohammed.jabbar@uobasrah.edu.iq   Tel:009647729508962

Received: 24 March 2026        Accepted: 20 June 2026        Published: 29 June 2026

Citation: Sattar M, Alshawi M, Jasim NN. Effect of superdisintegrant type and concentration on dissolution behaviour of Ondansetron orodispersible tablets. Trop J Pharm Res 2026; 25(6):787-795 doi: https://dx.doi.org/10.4314/tjpr.v25i6.4

© 2026 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the effect of various superdisintegrants on disintegration time and early-phase dissolution in ondansetron hydrochloride orodispersible tablets (ODTs). Methods: A total of 12 formulations were prepared by direct compression using a 3×4 full factorial design. Crospovidone (CPV), sodium starch glycolate (SSG), and croscarmellose sodium (CCS) were each tested at 2, 4, 6, and 8 % w/w. Primary responses were disintegration time, 5-minute drug release, dissolution similarity (f?), and Korsmeyer–Peppas exponent (n). Results: All blends had acceptable flow properties. At 8 % w/w, CPV released 77.2 % within 5 min compared to SSG (p < 0.01), f? = 45.3 between CPV and SSG indicated dissimilar profiles, and f? = 90.8 between SSG and CCS confirmed equivalent swelling-polymer behaviour. Korsmeyer–Peppas modelling gave n = 0.33 for CPV (Fickian diffusion) and n = 0.45, 0.44 for SSG and CCS, respectively, consistent with partial gel-layer resistance. Korsmeyer–Peppas rate constant showed kKP = 40.09 min-n for CPV compared to 7.13 min-n and 28.50 min-n for SSG and CCS, respectively. Furthermore, CPV produced faster early drug release compared to SSG and CCS at all concentrations. Conclusion: Crospovidone shows significantly superior early-phase dissolution at all concentrations compared with SSG and CCS

Keywords: Crospovidone, Korsmeyer–Peppas model, Ondansetron hydrochloride, Orodispersible tablets, Superdisintegrants

Impact Factor
Thompson Reuters (ISI): 0.6 (2023)
H-5 index (Google Scholar): 49 (2023)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal: